関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | N-vinyl-2-pyrrolidone | HCID 6917 | — |
| 反応物 | Sodium Hypochlorite | HCID 23665760 | — |
| 反応物 | 3-Piperidin-1-yl-propionaldehyde oxime | HCID 74057870 | — |
| 溶媒 | Chloroform | HCID 6212 | — |
| 生成物 | 1-[3-(2-Piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one | HCID 10015727 | 45% |
反応手順
To a solution of 646 μL (1.5 equivalent) of N-vinyl-pyrrolidin-2-one in 5 mL of chloroform, a biphasic solution of 7.4 mL (3.2 equivalents) of 13% Clorax (NaOCl) and a solution of 629.3 mg (4.03 mmol) of 3-piperidin-1-yl-propionaldehyde oxime compound prepared in Example 2 in 5 mL of chloroform were added slowly over 15 minutes with cooling to 0° C. and stirring vigorously. After reacting at room temperature overnight, the reaction mixture was extracted with chloroform three times, washed with a saturated aqueous solution of sodium carbonate twice following water once, dried over sodium sulfate, filtered and then concentrated under reduced pressure. The concentrate was purified by separation with silica gel column chromatography using chloroform/methanol (30:1) as eluent to obtain 477.4 mg (45% yield) of 1-[3-(2-piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one. Subsequently, 1:1 acid addition salt with oxalic acid was obtained from the diethyl ether solution.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US06759419B2 |
|---|
| 出典データセット | uspto-grants-2004_07 |
|---|
| ORD ID | ord-c215c43c539b429eb0c01714f31ab002 |
|---|
| 出典メモ | uspto-grants-2004_07 |
|---|